450 related articles for article (PubMed ID: 27671823)
1. Natural Withanolides in the Treatment of Chronic Diseases.
White PT; Subramanian C; Motiwala HF; Cohen MS
Adv Exp Med Biol; 2016; 928():329-373. PubMed ID: 27671823
[TBL] [Abstract][Full Text] [Related]
2. Withania somnifera and Its Withanolides Attenuate Oxidative and Inflammatory Responses and Up-Regulate Antioxidant Responses in BV-2 Microglial Cells.
Sun GY; Li R; Cui J; Hannink M; Gu Z; Fritsche KL; Lubahn DB; Simonyi A
Neuromolecular Med; 2016 Sep; 18(3):241-52. PubMed ID: 27209361
[TBL] [Abstract][Full Text] [Related]
3. Withanolides against TLR4-Activated Innate Inflammatory Signalling Pathways: A Comparative Computational and Experimental Study.
Purushotham PM; Kim JM; Jo EK; Senthil K
Phytother Res; 2017 Jan; 31(1):152-163. PubMed ID: 27859734
[TBL] [Abstract][Full Text] [Related]
4. Withanolides from Withania somnifera Dunal: development of cellular technology and their production.
Sangwan NS; Sabir F; Mishra S; Bansal S; Sangwan RS
Recent Pat Biotechnol; 2014; 8(1):25-35. PubMed ID: 24354530
[TBL] [Abstract][Full Text] [Related]
5. Molecular targets and mechanisms of cancer prevention and treatment by withaferin a, a naturally occurring steroidal lactone.
Vyas AR; Singh SV
AAPS J; 2014 Jan; 16(1):1-10. PubMed ID: 24046237
[TBL] [Abstract][Full Text] [Related]
6. Journey Describing the Cytotoxic Potential of Withanolides: A Patent Review.
Hussain H; Csuk R; Green IR; Ur Rehman N; Abbas G; Hussain W
Recent Pat Anticancer Drug Discov; 2018; 13(4):411-421. PubMed ID: 30091418
[TBL] [Abstract][Full Text] [Related]
7. Extraction Optimization for Phenolic- and Withanolide-Rich Fractions from
Kumar S; Singh R; Gajbhiye N; Dhanani T
J AOAC Int; 2018 Nov; 101(6):1773-1780. PubMed ID: 29945694
[No Abstract] [Full Text] [Related]
8. Recent Advances in the Chemistry and Therapeutic Evaluation of Naturally Occurring and Synthetic Withanolides.
Singh A; Raza A; Amin S; Damodaran C; Sharma AK
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164150
[TBL] [Abstract][Full Text] [Related]
9. Evaluating anticancer properties of Withaferin A-a potent phytochemical.
Atteeq M
Front Pharmacol; 2022; 13():975320. PubMed ID: 36339589
[TBL] [Abstract][Full Text] [Related]
10. Hypoglycemic activity of withanolides and elicitated Withania somnifera.
Gorelick J; Rosenberg R; Smotrich A; Hanuš L; Bernstein N
Phytochemistry; 2015 Aug; 116():283-289. PubMed ID: 25796090
[TBL] [Abstract][Full Text] [Related]
11. Withaferin A: From ayurvedic folk medicine to preclinical anti-cancer drug.
Hassannia B; Logie E; Vandenabeele P; Vanden Berghe T; Vanden Berghe W
Biochem Pharmacol; 2020 Mar; 173():113602. PubMed ID: 31404528
[TBL] [Abstract][Full Text] [Related]
12. Thiol dependent NF-κB suppression and inhibition of T-cell mediated adaptive immune responses by a naturally occurring steroidal lactone Withaferin A.
Gambhir L; Checker R; Sharma D; Thoh M; Patil A; Degani M; Gota V; Sandur SK
Toxicol Appl Pharmacol; 2015 Dec; 289(2):297-312. PubMed ID: 26408225
[TBL] [Abstract][Full Text] [Related]
13. Withanolides: Promising candidates for cancer therapy.
Zhang Q; Yuan Y; Cao S; Kang N; Qiu F
Phytother Res; 2024 Feb; 38(2):1104-1158. PubMed ID: 38176694
[TBL] [Abstract][Full Text] [Related]
14.
Dutta R; Khalil R; Green R; Mohapatra SS; Mohapatra S
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731424
[TBL] [Abstract][Full Text] [Related]
15. Withaferin A and its potential role in glioblastoma (GBM).
Dhami J; Chang E; Gambhir SS
J Neurooncol; 2017 Jan; 131(2):201-211. PubMed ID: 27837436
[TBL] [Abstract][Full Text] [Related]
16. Withania somnifera inhibits NF-kappaB and AP-1 transcription factors in human peripheral blood and synovial fluid mononuclear cells.
Singh D; Aggarwal A; Maurya R; Naik S
Phytother Res; 2007 Oct; 21(10):905-13. PubMed ID: 17562568
[TBL] [Abstract][Full Text] [Related]
17. Molecular docking, QSAR and ADMET studies of withanolide analogs against breast cancer.
Yadav DK; Kumar S; Saloni ; Singh H; Kim MH; Sharma P; Misra S; Khan F
Drug Des Devel Ther; 2017; 11():1859-1870. PubMed ID: 28694686
[TBL] [Abstract][Full Text] [Related]
18. Withaferin A inhibits NF-kappaB activation by targeting cysteine 179 in IKKβ.
Heyninck K; Lahtela-Kakkonen M; Van der Veken P; Haegeman G; Vanden Berghe W
Biochem Pharmacol; 2014 Oct; 91(4):501-9. PubMed ID: 25159986
[TBL] [Abstract][Full Text] [Related]
19. Potential Anticancer Properties and Mechanisms of Action of Withanolides.
Samadi AK
Enzymes; 2015; 37():73-94. PubMed ID: 26298456
[TBL] [Abstract][Full Text] [Related]
20. Enhanced withanolide production by overexpression of squalene synthase in Withania somnifera.
Grover A; Samuel G; Bisaria VS; Sundar D
J Biosci Bioeng; 2013 Jun; 115(6):680-5. PubMed ID: 23313565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
